ARTL Artelo Biosciences, Inc. Common Stock · XNAS
6.50 +4.5% as of Sep 4, 09:05 ET
fans
What's happening Reference profile Generated 09:29 ET
Share structure
Free float
—, refreshing
2026-05-22
Shares out
547.8K
latest detail
Market cap
$3.4M
at ref price
Short interest
3.1%
2026-08-14
Float rotation
0.00×
latest snapshot
20d dollar vol
$729.1K
baseline
Supply intelligence
Gap quality
mixed supply · 58
live supply-pressure model
Supply factor
very tight float
detector reason
Supply factor
nano-cap supply profile
detector reason
Supply factor
recent reverse split dilution risk
detector reason
Supply factor
thin dollar volume
detector reason

This estimates whether a gap is clean, squeeze-prone, mixed, or supply-heavy using float, float rotation, short interest, market cap, split risk, and live volume. Registered resale/ATM exhaustion is a planned deeper parser layer.

Filings and news
2026-09-04 09:05 ETSignalArtelo Biosciences, Inc. Common Stock is up 4.5%, at 6.50. Score 30. Primary driver: low float. Supply intelligence: mixed supply · 58.
2026-08-31Split1-for-9 reverse split logged
2026-08-278-KItem 3.03 — Material modification to rights of security holders; Item 5.03 — Amendments to charter or bylaws +1 more SEC
2026-08-1210-QQuarterly report SEC
2026-07-178-KCurrent report filed with SEC. SEC
2026-07-14 08:47 ETGeneralArtelo Biosciences Issues Reminder to Shareholders to Vote in Advance of Annual Meeting on July 17, 2026 News
2026-06-05DEF 14AProxy statement SEC
2026-05-278-KItem 1.01 — Entry into a material definitive agreement; Item 8.01 — Other events +1 more SEC
2026-05-26424B5Potential financing or dilution-related filing. SEC
2026-03-30 16:46 ETOfferingArtelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules News
2025-09-30 08:30 ETOfferingArtelo Biosciences Announces Pricing of $2.0 Million Public Offering News
2025-09-29 19:15 ETOfferingArtelo Biosciences Announces Proposed Underwritten Public Offering News
Latest detector signalscore 30
score 30